SPONSOR
Kite, A Gilead Company
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 3
Conditions studied: Chronic Inflammatory Demyelinating PolyneuropathyMyasthenia GravisMultiple SclerosisRelapsed or Refractory Large B-cell Lymphoma
Kite, A Gilead Company is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis, Relapsed or Refractory Large B-cell Lymphoma.
The trial portfolio spans Phase 1, Phase 3 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Kite, A Gilead Company
How many clinical trials has Kite, A Gilead Company sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Kite, A Gilead Company, of which 2 are actively recruiting participants. These trials cover conditions including Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Kite, A Gilead Company research focus on?
Kite, A Gilead Company clinical trials span Chronic Inflammatory Demyelinating Polyneuropathy, Myasthenia Gravis, Multiple Sclerosis, Relapsed or Refractory Large B-cell Lymphoma. The research pipeline includes Phase 1, Phase 3 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Kite, A Gilead Company clinical trial?
To participate in a Kite, A Gilead Company trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Kite, A Gilead Company trials with current recruitment status updated daily.
Clinical Trials by Kite, A Gilead Company
NCT07304154 Phase 1
Recruiting
A Study Evaluating the Safety and Efficacy of KITE-363 in Relapsed/Refractory Autoimmune Neurologic Diseases
Chronic Inflammatory Demyelinating Polyneuropathy
NCT07479797 Phase 3
Recruiting
Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refractory Large B-Cell Lymphoma After First-Line Therapy
Relapsed or Refractory Large B-cell Lymphoma
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology